FDA approves zanubrutinib for Waldenstr öm’s macroglobulinemia

Oncology News burst

Source: FDA Center for Drug Evaluation and Research - What's New - September 1, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news